Hence, the increased levels of SFRP4 in T2D patients possibly can reduce insulin exocytosis due to a decrease in beta cell function (Table 1 shows values of HOMA-B), which causes an impaired glucose uptake by cells, and promotes a raise of blood glucose. This evidence concerns the gene SFRP4 and type 2 diabetes mellitus.